Anesthesia & Analgesia · 1993 · 54 citations · 0 references
MedicineAnesthesiologyPharmacologyAnesthesiaClinical PharmacologyPediatric AnesthesiologyCardiovascular Effects Of AnesthesiaCardiovascular MonitoringHemodynamic Response To AnesthesiaPediatric AnesthesiaPediatric Anesthetic TechniquesPediatric PharmacologyArterial Blood Pressure MeasurementEpidural Test DoseHeart RateHeart Rate MonitoringHemodynamic Effects Of AnesthesiaIntravascular InjectionNitrous OxidePediatric Intravenous Anesthesia
The purpose of this study was to determine if isoproterenol would be an effective marker of intravascular injection in anesthetized children. Forty-four ASA 1 children, aged 2 mo to 10 yr, were randomly assigned to two groups. Children in group 1 (n = 21) received 0.05 microgram/kg isoproterenol, and children in group 2 (n = 23) received 0.075 microgram/kg isoproterenol. A blinded observer continuously recorded heart rate and arterial blood pressure. Measurements were recorded before the surgical incision at steady-state halothane concentration of 1.2 minimum alveolar concentration adjusted for age. Isoproterenol produced a graded increase in heart rate with mean maximum increases of 16.5 +/- 8.7 beats/min in group 1 and 21.5 +/- 9.2 beats/min in group 2. No episodes of hypotension and arrhythmia were noted. Isoproterenol, 0.075 microgram/kg, is more sensitive but still is an imperfect marker of an intravascular injection. It produces a heart rate increase in 96% of children anesthetized with halothane and nitrous oxide in 50% oxygen. The application of isoproterenol as an epidural test dose appears promising, but cannot be recommended until its full reliability and neurotoxicity are evaluated.